Peer Review History
| Original SubmissionOctober 22, 2019 |
|---|
|
PONE-D-19-29494 Eliciting preferences for outpatient care experiences in Hungary: A discrete choice experiment with a national representative sample PLOS ONE Dear Mr. Brito Fernandes, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Jan 19 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Matthew Quaife Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. Please provide your institutional email address. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study has applied a DCE to address a topic of increasing relevance, namely the relative importance of the domains of PREMs. I have some comments to make that I trust would improve the manuscript. 1. For International readers it would be helpful to have a brief background to primary health care in Hungary. For example the order of magnitude for co-payments or out of pocket costs would help the reader put the WTP values into context. The WTPs for aspects of care for non threatening health issue seem very high. 2. Some attribute levels seem very high and fall way beyond a realistic scenario. For example 3 month wait for appointments, 94 euros cost, 4 hour wait time. Using such extremes could lead to biased estimates of attribute preference and hence WTP. Is timely access to primary health care an issue in Hungary? 3. It is not clear why the authors have chosen both conditional and mixed logit models. This should be justified in the methods section. The more complex mixed logit does not provide any additional information to support the findings and does not seem to be justified. 4. The method used for sub group analyses should be explained. I assume models were run on separate data sets? If so as noted in the limitation this is not an ideal approach as individual respondents will be present in multiple sub groups. E.g. age and gender, education and income. Given the large data set, the authors could have considered inclusion of interaction variable for major sub groups on a trial and error basis. Or again given the large sample size a latent class model would have been a better approach to addressing preference heterogeneity than sub group analysis. I would recommend that the authors consider alternate approaches. 5. The probability calculations and plot are confusing. The base case that has a 4% probability is clear, however what attribute levels are used to produce the curve is not clear. It maybe that I am not following the method. Irrespective in my view the probability calculations do not add to the findings. Rather the WTP provide a simpler estimate of attribute importance. 6. Table 1 should include comparison to general population distributions for Hungary as this was a stated aim of recruitment. In summary, I suggest that the authors consider alternate approaches to addressing preference heterogeneity and respondent characteristics, for example using interaction variables or better still a latent class model. Reviewer #2: 1. The methodology section would benefit from reorganisation to ensure a proper flow that readers can follow. The authors can learn from guidelines on how to report choice experiments such as Bridges et al. 2011 https://doi.org/10.1016/j.jval.2010.11.013 2. Deriving attributes and levels is a very important step of a choice experiment. The authors need to comprehensively explain in the text how they arrived to the selected attributes and levels. Were literature reviews and qualitative studies conducted? How did they reduce the number of attributes and levels (were experts engaged, were patients involved?). Explain these aspects in the text 3. The study lacks an opt-out or status quo Can the authors provide a very good justification in the text for excluding either one of these? This is because the lack of an opt-out or status quo exposes your WTP estimates to criticism. 4. What is the justification of the choosing the D-efficient design over other designs that exist such as Bayesian efficient designs? Which software was used to generate the experimental design? Researchers should explain these issues in the text. 5. How did the authors derive their prior parameters for the D-efficient design? Did they use educated best guess or were the priors derived from the pilot study they conducted? The authors need to explain this in the text. Furthermore, which model did the authors optimise for in the experimental design? MNL, MMNL etc 6. Line 73: Though the sample was obtained from a panel of an internet survey company, the authors need to be a bit detailed on how the quota sampling approach had been implemented to sample the respondents. Explain this in the text. 7. Line 172 “we assumed error terms to be independently and identically distributed following a logistic regression". I suggest the authors should replace the term "logistic regression" with "type 1 extreme value distribution". 8. Line 181 assuming the parameter of the out-of-pocket payment attribute as fixed rather than random is misleading. It suggests that the standard deviation of unobserved utility of the out-of-pocket attribute is the same for all observations. The authors should rerun their mixed multinomial logit model with the out-of-pocket payment attribute assuming a random and lognormal distribution instead of fixed. 9. Line 197-line 205. The authors should make it clear here that they computed the WTP measures in preference space using the conditional logit model coefficients. However, the authors still compute WTP estimates in preference space using the Mixed Multinomial Logit Model coefficients. They assume that the out-of-pocket payment attribute parameter is fixed and compute WTP as a ratio of parameters (-attribute/out-of-pocket) which is known as preference space. However, This can result in WTP distributions that are not well behaved as the authors are not accounting for variability in the price attribute (our-of-pocket payments). Therefore, the authors have to rerun the WTP estimates for mixed multinomial logit model in WTP space with the price parameter assuming a lognormal distribution. see Train and Weeks 2005 https://doi.org/10.1007/1-4020-3684-1_1 10. Attach the DCE questionnaire as supplementary file ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Martin Robert Howell Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-19-29494R1 Eliciting preferences for outpatient care experiences in Hungary: A discrete choice experiment with a national representative sample PLOS ONE Dear Mr. Brito Fernandes, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Jun 01 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Matthew Quaife Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I have reviewed the responses to my comments and those of the second reviewer and am satisfied that the authors have made appropriate changes to the manuscript to address these. I look forward to the publication. Reviewer #2: I thank the authors for addressing some of the issues. However, after they rerun the models and revised their manuscript, some issues came up. I am still not satisfied with the manuscript. 1. The methods sections still doesn't flow yet. When reporting DCEs, the first thing in the methods section should be attribute and levels selection or study setting followed by attributes and levels. Your paper starts with how data were collected before outlining what was being collected. There already exists a checklist for reporting Health related DCEs e.g. Bridges 2011 You can rearrange your methods section as follows 1. Attribute selection [or study setting can come before attributes and levels] 2. Attribute levels selection 3. DCE tasks and Experimental design 4. Preference elicitation 5. Instrument design [This is what you call survey in your paper. Write about the sections of your questionnaire] 6. Data collection [ This is where you include the data collection section including ethical approval] 7. Statistical analyses 2. You aimed for sample size of 1000. What was this number based on? Rule of thumb, parametric method for calculating the sample size? State that in the text on how you derived the minimum sample size required. 3. The reason for excluding an opt-out or status quo is not convincing as in real market scenario a Hungarian patient can choose to opt-out of care or seeking care elsewhere. Though you assumed that the respondents would seek care, in your choice scenario, you did state that the health problem did not require immediate care. Patients should then have been allowed to opt-out as they can choose to delay care as it did not need immediate treatment. The opt-out could have possibly been labelled 'delay care' The repercussions for leaving out the opt-out is that it exacerbates hypothetical bias which further biases your WTP estimates. Therefore, you need to state this in your limitations. Furthermore, studies can still be designed in a way that includes and excludes the opt-out by for having two choice questions. For example, for those who choose the opt-out, you can ask them an additional question that forces them to choose between Alternative A or B only. 4. Line 198 "it would jeopardise a better understanding on respondents’preferences if a large number of respondents choose the opt-out option". This sentence would be better rephrased as "including the opt-out would not provide much information. However, this exposes the DCE to hypothetical bias as in real market scenario patients can opt-out of care or delay care. 5. Line 386. "Left bias". Did you mean "left-right" bias. In the model specification line 278, you state that where B0 is an alternative-specific constant that indicates respondents’ preference for consultation A vs. consultation B. But in your results tables 3,4,5 you define alternative specific constant as constant of choosing alternative B. This is a bit confusing. Is your alternative specific constant for Alternative A or Alternative B? Confirm 6. You have not stated in the statistical analyses section how you calculated your relative importance of attributes. You have provided information on how to calculated choice probabilities (preference weights) and WTP estimates but not relative importance estimates. 7. Tables 3,4,5, For the dummy coded variables, could you also state what the base levels were in the tables? 8. Line 465 "The standard deviation of the WTP estimates were high, suggesting a large preference heterogeneity across respondents" did you mean large heterogeneity in WTP estimates? Rectifying the wording used 9. By using the term ‘independent random’ throughout the text, do you mean ‘random and normally distributed’? 10. line 507 "To compute estimates in WTP space we used Stata’s user-written mixlogitwtp module". You had already mentioned this in the statistical analyses section 11. Check your interpretation of WTP estimates, they have to be relative to the base. e.g Patients were willing to pay. 12. Your discussion section is very weak. Authors need to be a bit detailed in discussing their findings in light of their research objectives and compare their finding with other studies in similar settings. Also, the authors should have some strong policy recommendations. They have attempted these, but it is too weak. The discussion section needs to be strengthened Make these adjustments and let’s see how the manuscript looks. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Martin Howell Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Eliciting preferences for outpatient care experiences in Hungary: A discrete choice experiment with a national representative sample PONE-D-19-29494R2 Dear Dr. Brito Fernandes, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Matthew Quaife Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-29494R2 Eliciting preferences for outpatient care experiences in Hungary: A discrete choice experiment with a national representative sample Dear Dr. Brito Fernandes: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Matthew Quaife Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .